5/7
02:23 pm
ovid
Ovid Therapeutics Inc. (NASDAQ: OVID) had its price target lowered by analysts at Citigroup Inc. from $4.00 to $3.50. They now have a "neutral" rating on the stock.
Low
Report
Ovid Therapeutics Inc. (NASDAQ: OVID) had its price target lowered by analysts at Citigroup Inc. from $4.00 to $3.50. They now have a "neutral" rating on the stock.
4/30
08:20 am
ovid
Ovid Therapeutics Inc. (NASDAQ: OVID) is now covered by analysts at B. Riley. They set a "buy" rating and a $9.00 price target on the stock.
Medium
Report
Ovid Therapeutics Inc. (NASDAQ: OVID) is now covered by analysts at B. Riley. They set a "buy" rating and a $9.00 price target on the stock.
4/29
08:03 am
ovid
Ovid Therapeutics Inc. (NASDAQ: OVID) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $9.00 price target on the stock.
Medium
Report
Ovid Therapeutics Inc. (NASDAQ: OVID) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $9.00 price target on the stock.
4/26
11:59 am
ovid
Ovid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher? [Yahoo! Finance]
Low
Report
Ovid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher? [Yahoo! Finance]
4/18
06:23 am
ovid
We Think Ovid Therapeutics (NASDAQ:OVID) Can Afford To Drive Business Growth [Yahoo! Finance]
Medium
Report
We Think Ovid Therapeutics (NASDAQ:OVID) Can Afford To Drive Business Growth [Yahoo! Finance]
4/9
11:04 am
ovid
Ovid Therapeutics: Data Readouts For Rare Epileptic Indications Late 2024 [Seeking Alpha]
Low
Report
Ovid Therapeutics: Data Readouts For Rare Epileptic Indications Late 2024 [Seeking Alpha]
4/5
08:03 am
ovid
Ovid Therapeutics Inc. (NASDAQ: OVID) is now covered by analysts at Wedbush. They set an "outperform" rating and a $8.00 price target on the stock.
Low
Report
Ovid Therapeutics Inc. (NASDAQ: OVID) is now covered by analysts at Wedbush. They set an "outperform" rating and a $8.00 price target on the stock.
4/4
08:10 am
ovid
Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
Low
Report
Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
4/4
08:00 am
ovid
Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Low
Report
Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
3/27
08:45 am
ovid
Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus' Post Grant Review [Yahoo! Finance]
Low
Report
Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus' Post Grant Review [Yahoo! Finance]
3/22
06:13 am
ovid
Ovid Therapeutics Reaches US$197m Market Cap Benefiting Insider Stock Buying [Yahoo! Finance]
Medium
Report
Ovid Therapeutics Reaches US$197m Market Cap Benefiting Insider Stock Buying [Yahoo! Finance]
3/8
08:12 am
ovid
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Low
Report
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
3/8
08:00 am
ovid
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
Low
Report
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
2/28
08:00 am
ovid
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
Medium
Report
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
2/27
01:08 pm
ovid
Dup15q Syndrome Drug Market is Projected to Grow Significantly During the Study Period (2019–2032) | DelveInsight [Yahoo! Finance]
Neutral
Report
Dup15q Syndrome Drug Market is Projected to Grow Significantly During the Study Period (2019–2032) | DelveInsight [Yahoo! Finance]